Analysis of hepatitis B surface antigen mutations in Mongolia: Molecular epidemiology and implications for mass vaccination

Archives of Virology

Volumn 152, Issue 3, 2007, Pages 575-584

  Davaalkham, Dambadarjaa ^a,b   Ojima, T ^c   Uehara, R ^a   Watanabe, M ^a   Oki, I ^a   Endo, K ^a   Takahashi, M ^a   Okamoto, H ^a   Nakamura, Y ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b MONGOLIAN NATIONAL UNIVERSITY OF MEDICAL SCIENCES   (Mongolia)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CLASSIFICATION; FEMALE; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MOLECULAR GENETICS; MONGOLIA; MOTHER; MUTATION; NUCLEOTIDE SEQUENCE; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CHILD; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MONGOLIA; MOTHERS; MUTATION; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID;

HEPATITIS B VIRUS;

EID: 33847690779     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-006-0863-3     Document Type: Article

References (35)

1. Alestig E, Hannoun C, Horal P, Lindh M (2001) Hepatitis B virus genotypes in Mongols and Australian Aborigines. Arch Virol 146: 2321-2329
2. Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, Dienstag JL, Awdeh Z, Yunis EJ (1989) Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 321: 708-712
3. Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO (2002) Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83: 2059-2073
4. Avellon A, Echevarria JM (2006) Frequency of hepatitis B virus 'a' determinant variants in unselected Spanish chronic carriers. J Med Virol 78: 24-36
5. Basuni AA, Butterworth L, Cooksley G, Locarnini S, Carman WF (2004) Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine 22: 2791-2799
6. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC (1990) Vaccine-induced escape mutant of hepatitis B virus. Lancet 336: 325-329
7. Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, Decker R, Sanders R (1997) The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 26: 1658-1666
8. Davaalkham D, Ojima T, Nymadawa P, Uehara R, Watanabe M, Oki I, Nakamura Y (2006) Prevalence and risk factors for hepatitis C virus infection in Mongolian children: Findings from a Nationwide Survey. J Med Virol 78: 466-472
9. Davaalkham D, Ojima T, Uehara R, Watanabe M, Oki I, Nymadawa P, Takahashi M, Okamoto H, Nakamura Y (2006) Hepatitis delta virus infection in Mongolia: Analyses of geographic distribution, risk factors and disease severity. Am J Trop Med Hyg 75: 365-369
10. Davaalkham D, Ojima T, Nymadawa P, Tsend N, Lkhagwasuren TS, Wiersma S, Uehara R, Watanabe M, Oki I, Nakamura Y (2007) Seroepidemiology of hepatitis B virus infection in Mongolian children: A Nationwide Survey. Pediatr Int 49 (3) (in press)
11. Echevarria JM, Avellon A (2006) Hepatitis B virus genetic diversity. J Med Virol 78: 36-42
12. Felsenstein J (1985) Confidence limits on phylogenesis: an approach using the bootstrap. Evolution 39: 783-791
13. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL (1999) Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30: 1312-1317
14. Ina Y (1994) ODEN: a program package for molecular evolutionary analysis and database search of DNA and amino acid sequences. Comput Appl Biosci 10: 11-12
15. Ireland JH, O'Donnell B, Basuni AA, Kean JD, Wallace LA, Lau GK, Carman WF (2000) Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 31: 1176-1182
16. Lee PI, Chang LY, Lee CY, Huang LM, Chang MH (1997) Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J Infect Dis 176: 427-430
17. McMahon BJ (2005) Epidemiology and natural history of hepatitis B. Semin Liver Dis 25 Suppl 1: 3-8
18. Mele A, Tancredi F, Romano L, Giuseppone A, Colucci M, Sangiuolo A, Lecce R, Adamo B, Tosti ME, Taliani G, Zanetti AR (2001) Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 184: 905-908
19. National Center for Health Development, Ministry of Health of Mongolia. Annual Health Report-2004. Ulaanbaatar, 2004. http://www.moh.mn/ (accessed 10 June 2006)
20. Norder H, Hammas B, Lofdahl S, Courouce AM, Magnius LO (1992) Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 73: 1201-1208
21. Norder H, Courouce AM, Magnius LO (1994) Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198: 489-503
22. Ogata N, Cote PJ, Zanetti AR, Miller RH, Shapiro M, Gerin J, Purcell RH (1999) Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus. Hepatology 30: 779-786
23. Okamoto H, Imai M, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M (1987) Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol 61: 3030-3034
24. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M (1988) Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69: 2575-2583
25. Oon CJ, Lim GK, Ye Z, Goh KT, Tan KL, Yo SL, Hopes E, Harrison TJ, Zuckerman AJ (1995) Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 13: 699-702
26. Oon CJ, Chen WN, Koh S, Lim GK (1999) Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants. J Infect Dis 179: 259-263
27. Poovorawan Y, Theamboonlers A, Chongsrisawat V, Sanpavat S (1998) Molecular analysis of the a determinant of HBsAg in children of HBeAg-positive mothers upon failure of postexposure prophylaxis. Int J Infect Dis 2: 216-220
28. Purcell RH (2000) Hepatitis B virus mutants and efficacy of vaccination. Lancet 356: 769-770
29. Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425
30. Srey CT, Ijaz S, Tedder RS, Monchy D (2006) Characterization of hepatitis B surface antigen strains circulating in the Kingdom of Cambodia. J Viral Hepat 13: 62-66
31. Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R (2000) A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81: 67-74
32. Takahashi M, Nishizawa T, Gotanda Y, Tsuda F, Komatsu F, Kawabata T, Hasegawa K, Altankhuu M, Chimedregzen U, Narantuya L, Hoshino H, Hino K, Kagawa Y, Okamoto H (2004) High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia. Clin Diagn Lab Immunol 11: 392-398
33. Zanetti AR, Tanzi E, Manzillo G, Maio G, Sbreglia C, Caporaso N, Thomas H, Zuckerman AJ (1988) Hepatitis B variant in Europe. Lancet 2: 1132-1133
34. Zuckerman AJ (2000) Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet 355: 1382-1384
35. Zuckerman JN, Zuckerman AJ (2003) Mutations of the surface protein of hepatitis B virus. Antiviral Res 60: 75-78